MicroRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression

Biochemical and Biophysical Research Communications

Volumn 456, Issue 3, 2015, Pages 804-809

  Han, Guangye ^a   Fan, Maochuan ^a   Zhang, Xinjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; miR 218; Prostate cancer; TPD52

Indexed keywords

MICRORNA; MICRORNA 218; TUMOR PROTEIN; TUMOR PROTEIN D52; UNCLASSIFIED DRUG; MIRN218 MICRORNA, HUMAN; TPD52 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN FUNCTION; GENE SILENCING; GENETICS; HEK293 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MALE; MICRORNAS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS;

EID: 84920728886     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.026     Document Type: Article

References (22)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics CA Cancer J. Clin. 64 2014 2014 9 29
2. A. Egan, Y. Dong, H. Zhang, Y. Qi, S.P. Balk, and O. Sartor Castration-resistant prostate cancer: adaptive responses in the androgen axis Cancer Treat. Rev. 40 2014 426 433
3. M.A. Rubin, S. Varambally, R. Beroukhim, S.A. Tomlins, D.R. Rhodes, P.L. Paris, M.D. Hofer, M. Storz-Schweizer, R. Kuefer, J.A. Fletcher, B.L. Hsi, J.A. Byrne, K.J. Pienta, C. Collins, W.R. Sellers, and A.M. Chinnaiyan Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer Cancer Res. 64 2004 3814 3822
4. A.E. Ross, L. Marchionni, M. Vuica-Ross, C. Cheadle, J. Fan, D.M. Berman, and E.M. Schaeffer Gene expression pathways of high grade localized prostate cancer Prostate 71 2011 1568 1577
5. T. Nakagawa, T.M. Kollmeyer, B.W. Morlan, S.K. Anderson, E.J. Bergstralh, B.J. Davis, Y.W. Asmann, G.G. Klee, K.V. Ballman, and R.B. Jenkins A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy PLoS ONE 3 2008 e2318
6. R. Ummanni, S. Teller, H. Junker, U. Zimmermann, S. Venz, C. Scharf, J. Giebel, and R. Walther Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells FEBS J. 275 2008 5703 5713
7. L. Li, D. Zhang, L. Zhang, G. Zhu, Y. Sun, K. Wu, X. Wang, and D. He PrLZ expression is associated with the progression of prostate cancer LNCaP cells Mol. Carcinog. 48 2009 432 440
8. H. Zhang, J. Wang, B. Pang, R.X. Liang, S. Li, P.T. Huang, R. Wang, L.W. Chung, H.E. Zhau, C. Huang, and J.G. Zhou PC-1/PrLZ contributes to malignant progression in prostate cancer Cancer Res. 67 2007 8906 8913
9. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
10. J.A. Byrne, S. Frost, Y. Chen, and R.K. Bright Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene? Tumour Biol. 35 2014 7369 7382
11. I. Haecker, L.A. Gay, Y. Yang, J. Hu, A.M. Morse, L.M. McIntyre, and R. Renne Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas PLoS Pathog. 8 2012 e1002884
12. A.G. Bader MiR-34 - a microRNA replacement therapy is headed to the clinic Front. Genet. 3 2012 120
13. Y. Goto, R. Nishikawa, S. Kojima, T. Chiyomaru, H. Enokida, S. Inoguchi, T. Kinoshita, M. Fuse, S. Sakamoto, M. Nakagawa, Y. Naya, T. Ichikawa, and N. Seki Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer FEBS Lett. 588 2014 1973 1982
14. S. Tatarano, T. Chiyomaru, K. Kawakami, H. Enokida, H. Yoshino, H. Hidaka, T. Yamasaki, K. Kawahara, K. Nishiyama, N. Seki, and M. Nakagawa MiR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer Int. J. Oncol. 39 2011 13 21
15. W.M. Fu, L.P. Tang, X. Zhu, Y.F. Lu, Y.L. Zhang, W.Y. Lee, H. Wang, Y. Yu, W.C. Liang, C.H. Ko, H.X. Xu, H.F. Kung, and J.F. Zhang MiR-218-targeting-Bmi-1 mediates the suppressive effect of 1,6,7-trihydroxyxanthone on liver cancer cells Apoptosis 2014
16. A. Uesugi, K. Kozaki, T. Tsuruta, M. Furuta, K. Morita, I. Imoto, K. Omura, and J. Inazawa The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer Cancer Res. 71 2011 5765 5778
17. N.M. Alajez, M. Lenarduzzi, E. Ito, A.B. Hui, W. Shi, J. Bruce, S. Yue, S.H. Huang, W. Xu, J. Waldron, B. O'Sullivan, and F.F. Liu MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway Cancer Res. 71 2011 2381 2391
18. C.M. Haaland, C.M. Heaphy, K.S. Butler, E.G. Fischer, J.K. Griffith, and M. Bisoffi Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization Int. J. Oncol. 35 2009 537 546
19. W. Liu, C.C. Xie, C.Y. Thomas, S.T. Kim, J. Lindberg, L. Egevad, Z. Wang, Z. Zhang, J. Sun, J. Sun, P.P. Koty, A.K. Kader, S.D. Cramer, G.S. Bova, S.L. Zheng, H. Gronberg, W.B. Isaacs, and J. Xu Genetic markers associated with early cancer-specific mortality following prostatectomy Cancer 119 2013 2405 2412
20. Z.H. Fei, K. Wu, Y.L. Chen, B. Wang, S.R. Zhang, and S.L. Ma Capilliposide isolated from Lysimachia capillipes Hemsl. induces ROS generation, cell cycle arrest, and apoptosis in human nonsmall cell lung cancer cell lines Evid Based Complement. Alternat. Med. 2014 2014 497456
21. A. Kourtidis, R. Jain, R.D. Carkner, C. Eifert, M.J. Brosnan, and D.S. Conklin An RNA interference screen identifies metabolic regulators NR1D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signature Cancer Res. 70 2010 1783 1792
22. S.S. El Sheikh, J. Domin, P. Abel, G. Stamp, and N. Lalani el Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF Neoplasia 6 2004 846 853